After decades of dramatic surgical innovations in pediatric living donor liver transplantation (LDLT), LDLT for biliary atresia (BA) still poses various challenges. This study reviewed our experience with LDLT for children with post-Kasai BA and evaluated outcomes and prognostic factors. From 2005 to 2016, 168 post-Kasai BA LDLT patients were enrolled and divided into 3 groups by age. Patient characteristics and perioperative data were compared. Predictors of morbidity and mortality following LDLT were analyzed in 93 infants. Outcome was relatively worse in infants than older children, with overall survival at 1 and 5 years of 94.5% and 93.2%, respectively, and graft survival at 1 and 5 years of 91.1% each. Incidence of vascular complications was not significantly higher in infants. High Pediatric End-Stage Liver Disease (PELD) score (odds ratio [OR], 3.72; 95% confidence interval [CI], 1.30-10.67; P 5 0.02) and portal vein (PV) hypoplasia (OR, 3.23; 95% CI, 1.10-9.52; P 5 0.03) were independent risk factors for morbidity. Low weight-for-age z score (hazard ratio, 5.76; 95% CI, 1.05-31.47; P 5 0.03) was identified as a significant risk factor for mortality after LDLT, but not age or absolute body weight (BW). Infants with BW deficit had a significantly smaller PV diameter (P 5 0.005), greater blood loss (P 5 0.001), and higher incidence of postoperative bacteremia (P 5 0.01). In conclusion, high PELD score and PV hypoplasia were independent risk factors for morbidity, and BW deficit was associated with poor survival in infants with post-Kasai BA after LDLT. However, LDLT in these infants at the earliest possible time after referral is a feasible option with excellent patient survival in an experienced center.
Biliary atresia (BA) is an idiopathic neonatal cholangiopathy characterized by progressive inflammatory obliteration of the intrahepatic or extrahepatic bile ducts.
(1) Although Kasai hepatoportoenterostomy (KPE) has dramatically improved outcomes in children with BA, (2) this condition is still one of the most common indications for pediatric living donor liver transplantation (LDLT). (3) Liver transplantation (LT) in patients with BA involves challenging techniques, including portal vein (PV) anastomosis in cases of PV hypoplasia due to a previous KPE and recurrent cholangitis, (4, 5) or meticulous dissection of severe intraabdominal adhesions. To date, several groups have reported the outcomes following LT for children with BA. (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) Of these, only a few large-scale studies have analyzed the prognostic factors for outcomes after LT. Furthermore, most of these studies were conducted over a decade ago and included various types of transplant procedures. (6) (7) (8) (9) 15) Innovations in surgery and perioperative management during the past 3 decades have significantly improved outcomes of pediatric LDLT. Recent advances in the management of size-mismatched grafts have decreased the complications related to large-for-size grafts, and thus have made LDLT a more accessible option for small children, (17) (18) (19) although morbidity and mortality in infants with BA remain higher than in older children because of technical difficulties. (10, 12, 15) However, no studies have investigated the predictors of outcomes in infants with post-Kasai BA who undergo LDLT. The aims of this retrospective study were to review our experience over the past decade with LDLT for children with post-Kasai BA and to analyze the outcomes and pretransplant prognostic factors affecting morbidity and mortality following LDLT in infants.
Patients and Methods

PATIENTS
From November 2005 to August 2016, a total of 388 consecutive pediatric patients (<18 years old) underwent LDLT at the National Center for Child Health and Development, Tokyo, Japan. Of these, 173 patients with BA underwent LDLT. After excluding 5 recipients who underwent primary LDLT without KPE, 168 patients with post-Kasai BA (55 boys, 113 girls) were enrolled in this study. Indications for LDLT in patients with post-Kasai BA include prolonged cholestasis, recurrent cholangitis, complications of portal hypertension (esophageal varices, hypersplenism, gastrointestinal bleeding), growth retardation, intrapulmonary shunting, pulmonary hypertension, and other symptoms such as itching.
Immunosuppressive therapy consisted of tacrolimus and low-dose steroids. (20) Informed consent was obtained from all donors and recipients before enrollment, and their anonymity was preserved. The study was approved by the ethics committee of the National Center for Child Health and Development and conducted in accordance with the Declaration of Helsinki (2008).
DONOR SELECTION
Briefly, donor candidates were selected from parents and individuals within the third degree of consanguinity with the recipients. Informed consent was obtained from all living donors. Donor age was restricted to 64 years. Suitability of potential donors was evaluated by various examinations including blood counts, blood chemistry, degree of liver steatosis, tumor markers, infection screen, blood and human leukocyte antigen type, and mixed lymphocyte reaction assay. Steatosis was assessed using the liver-to-spleen computed tomography (CT) attenuation ratio, and only potential donors with a ratio 1.2 were selected. (21) GRAFT SELECTION Graft evaluation at our center is based on imaging studies, including Doppler ultrasonography and CT volumetry. Doppler ultrasonography was performed by radiologists on admission and within a week before LDLT to evaluate vascular anatomy, PV diameter and direction/velocity of flow, presence of PV thrombosis, and liver echogenicity. Preoperative imaging of biliary anatomy was not routinely performed, and magnetic resonance cholangiopancreatography was performed if necessary. Graft selection was based mainly on the estimated graft-to-recipient weight ratio (GRWR) using CT volumetry, as previously described. (17, 18) Briefly, in infants, if the estimated GRWR of the left lateral segment (LLS) of the donor was >4.0%, reduction of the LLS was considered. Next, if the ratio of the LLS graft thickness measured on CT images was 1.0, a segment 2 graft was selected. If the ratio of graft thickness was <1.0, further nonanatomical reduction of the LLS graft was considered. Among recipients who were above school-age, the graft selection policy was based on that in adults. (22) LDLT was performed by 3 experienced surgeons (M.K., S.S., and A.F.) following a standardized technical procedure. The surgical procedure has been described in detail elsewhere. (23) 
STUDY DESIGN
Patients were divided into 3 groups by age as follows: < 1 year (group 1, n 5 93); 1-5 years (group 2, n 5 47); and 6-17 years (group 3, n 5 28). Patient characteristics, surgical outcomes, postoperative complications, and overall survival were compared between the 3 groups. Next, prognostic factors affecting morbidity and mortality in infants after LDLT were analyzed by univariate and multivariate analysis. The patients were then divided into 2 groups according to identified risk factors for patient survival, and a detailed analysis of perioperative outcomes was performed.
STUDY VARIABLES
Clinical data were collected from electronic medical records, and the following details were recorded: pretransplant patient condition, sex, age, body weight (BW), Pediatric End-Stage Liver Disease (PELD) score, presence of congenital anomalies (including cardiac anomalies, situs inversus, preduodenal PV, polysplenia, and absence of retrohepatic vena cava), number of previous laparotomies, donor type (maternal or paternal), ultrasonography findings (including PV diameter and flow), serum albumin, bilirubin, cholinesterase, international normalized ratio of prothrombin time (PT-INR), and the presence of infections or other complications. Surgical data were documented from operation records. Laboratory parameters during the week before LDLT were collected in all cases.
The weight-for-age and height-for-age z scores were calculated preoperatively for each patient as follows (24) : z score 5 (measured value -mean value in normal population) / standard deviation of the normal population with the same age and sex.
Mean values and standard deviations were obtained from the National Growth Survey conducted by the Japanese Ministry of Health, Labor and Welfare in 2010. The z score was calculated using data obtained immediately before LDLT. BW deficit was defined as a weight-for-age z score of < 22.
Postoperative complications in the recipients were graded according to the Clavien-Dindo classification system, (25) with posttransplant morbidity defined as grade 3b (including mortalities). The PV was defined as hypoplastic if the diameter was <4 mm. (5) The definitions of bacteremia have been described elsewhere. (26) 
STATISTICAL ANALYSIS
Continuous variables were compared with the Kruskal-Wallis test or Mann-Whitney U test, and categorical variables were compared using the v 2 test as appropriate. Continuous variables are expressed as medians and ranges. Overall survival was determined using the Kaplan-Meier method. Risk factors for postoperative morbidity were identified using univariate and multivariate logistic regression analysis, and prognostic factors for survival were identified using univariate Cox proportional hazards models. Receiver operating characteristic curves were plotted, and areas under the curve were calculated to determine the optimal cutoff values for PELD score, time interval between KPE and LDLT, and serum liver function indices in the analysis of prognostic factors. Any variable that was identified as significant (P < 0.05) in univariate analysis was considered a candidate for multivariate analysis. All analyses were 2-sided, and P < 0.05 was considered statistically significant. All data were analyzed using SPSS software, version 21 (IBM SPSS, Chicago, IL).
Results
PATIENT CHARACTERISTICS COMPARED BETWEEN AGES
Median age of the 168 recipients at LDLT was 0.9 years (range, 0.3-17.3 years); median BW was 7.3 kg (range, 3.7-63.8 kg); and median height was 66.2 cm (range, 53.6-174.0 cm). Pretransplant characteristics in the 3 groups are summarized in Table 1 . The proportion of recipients admitted to the intensive care unit (ICU; P 5 0.005) or hospitalized (P < 0.001) prior to LDLT was significantly higher in group 1 than in groups 2 and 3. Serum albumin was significantly lower, and serum bilirubin and PT-INR were significantly higher in group 1 than in groups 2 and 3 (P < 0.001). Median PELD score was significantly higher (14 versus 0 versus 4; P < 0.001) and weight-for-age and height-for-age z scores were significantly lower (weight, 21.6 versus 20.7 versus 20.6; height, 21.7 versus 21.6 versus 20.1; P < 0.001 for both) in group 1 than in the other groups. Primary indications for LDLT included jaundice (n 5 75; 80.6%), cholangitis (n 5 12; 12.9%), and gastrointestinal bleeding/growth retardation (n 5 1 each; 1.1%) in group 1; jaundice (n 5 16; 34.0%), cholangitis (n 5 15; 31.9%), and gastrointestinal bleeding (n 5 10; 21.3%) in group 2; and cholangitis (n 5 10; 35.7%), gastrointestinal bleeding (n 5 6; 21.4%), and jaundice (n 5 4; 14.3%) in group 3 ( Fig. 1 ).
SURGICAL OUTCOMES AND DONOR CHARACTERISTICS COMPARED BETWEEN AGES
Surgical outcomes and donor characteristics in the 3 groups are summarized in Table 2 . Operating time was significantly longer in group 3 than in the other groups (492 versus 483 versus 644 minutes; P < 0.001). Median amount of blood loss (99.6 versus 48.0 versus 58.1 g/kg; P < 0.001) and GRWR (3.3% versus 2.4% versus 1.2%; P < 0.001) were significantly higher in group 1 than in the other groups. Incidence of PV complications in group 1 tended to be higher than in the other groups, but the difference was not statistically significant (10.8% versus 0% versus 7.1%; P 5 0.07).
Donors in group 1 were significantly younger than in the other groups. In group 1, reduced-size LLS graft was used in 49 patients (52.7%). All patients received a graft from a parent.
During a median follow-up of 3.7 years, overall survival in groups 1, 2, and 3 was 94.5%, 100%, and 96.2%, respectively, at 1 year and 93.2%, 100%, and 96.2% at 5 years, and graft survival was 91.1%, 97.8%, and 96.2%, respectively, at 1 and 5 years. Although overall survival (P 5 0.19; Fig. 2A the 3 groups, both survival rates tended to be worse in group 1 than in the other groups.
DETAILS OF DECEASED RECIPIENTS WITH POST-KASAI BA AFTER LDLT
Clinical details of 7 (4.2%) patients with post-Kasai BA who died after LDLT are summarized in Table 3 . The number of revisions prior to LDLT was 0 in 3 recipients, 1 in 2 recipients, and 2 and 3 in 1 recipient each. The primary indications for LDLT included jaundice (n 5 5), hypersplenism (n 5 1), and cholangitis (n 5 1).
The median age at LDLT was 7 months, and 6 of the 7 recipients underwent LDLT at <1 year of age. A total of 4 out of 6 infant recipients had already developed malnutrition at the time of admission and failed to gain weight adequately despite sufficient nutritional management prior to LDLT. The main cause of death was sepsis in 5 patients, graft dysfunction caused by PV thrombosis in 1 patient, and progressive intrapulmonary shunt because of PV occlusion in 1 patient.
PRETRANSPLANT RISK FACTORS FOR MORBIDITY FOLLOWING LDLT IN INFANTS
Posttransplant morbidity (n 5 25) comprised the following: reoperation for intraabdominal abscess/bleeding/perforation/internal hernia (n 5 5/1/1/1), PV stenosis/thrombosis (n 5 5/1), biliary stricture (n 5 2), reintubation for mechanical ventilation caused by respiratory failure (n 5 2), hepatic venous outflow obstruction (n 5 1), and posttransplant death (n 5 6).
Results of univariate analysis of pretransplant risk factors for morbidity after LDLT in infants are shown in Multivariate analysis with these candidate variables revealed that high PELD score >14 (OR, 3.72; 95% CI, 1.30-10.67; P 5 0.02) and PV hypoplasia (OR, 3.23; 95% CI, 1.10-9.52; P 5 0.03) were independent risk factors for morbidity after LDLT (Table 5) .
PRETRANSPLANT RISK FACTORS FOR OVERALL SURVIVAL FOLLOWING LDLT IN INFANTS
Results of univariate analysis of pretransplant risk factors for overall survival after LDLT are shown in Table  6 . Low weight-for-age z score < -2 (26/93 [28.0%]; hazard ratio [HR], 5.76; 95% CI, 1.05-31.47; P 5 0.03) was identified as a significant risk factor for posttransplant mortality. In contrast, number of previous laparotomies 2, age at LDLT of <6 months, BW of < 6 kg, and presence of any congenital anomalies were not identified as risk factors.
COMPARISON OF PERIOPERATIVE OUTCOMES IN INFANTS
Comparison of pretransplant characteristics and surgical parameters in recipients <1 year between those with BW deficit (n 5 26) and those without BW deficit (n 5 67) is summarized in Table 7 . Median PELD score (19 versus 13; P 5 0.005) and number of previous laparotomies were significantly higher, and serum cholinesterase was significantly lower in patients with BW deficit than in those without BW deficit (112 versus 166 IU/L; P 5 0.004). Regarding surgical parameters, of note, median diameter of the PV was significantly smaller in patients with BW deficit than in those without BW deficit (3.0 versus 4.0 mm; P 5 0.005), and the amount of blood loss was significantly higher in the former than in the latter (154.6 versus 80.0 g/kg; P 5 0.001).
Comparison of posttransplant outcomes between the 2 groups is summarized in Table 8 . Incidence of postoperative bacteremia was significantly higher in the group with BW deficit than in the group without BW deficit (42.3% versus 14.9%; P 5 0.01). The number of patients with ascites >1 L on postoperative day (POD) 30 in the group with BW deficit tended to be higher than that in the group without BW deficit, but the difference was not significant (15.4% versus 6.0%; P 5 0.21). Incidence of biliary or PV complications, reoperation, and retransplantation did not differ between the 2 groups.
With a median follow-up of 3.6 years, survival rates in patients with BW deficit and those with no BW deficit were 88.1% and 96.9%, respectively, at 1 year and 83.2% and 96.9%, respectively, at 5 years. Overall survival was significantly worse in patients with BW deficit than in those without BW deficit (P 5 0.02; Fig. 3A ), whereas graft survival did not differ significantly (P 5 0.12; Fig. 3B ). 
Data are given as n (%) or median (range). Statistically significant P values are shown in bold.
FIG. 3.
Overall and graft survival according to BW deficit at LDLT in infants. (A) Overall survival was significantly worse in patients with BW deficit than in patients without (P 5 0.02), whereas (B) graft survival was not significantly different (P 5 0.12). NOTE: Data are given as n (%). Statistically significant P values are shown in bold.
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Discussion
In this study, we reported our experience with 168 pediatric LDLT recipients with post-Kasai BA at a high-volume Japanese institution and demonstrated that high PELD score and PV hypoplasia were independent risk factors for morbidity. We also demonstrated that BW deficit or malnutrition was associated with mortality after LDLT in infants with post-Kasai BA, whereas absolute BW, interval between KPE and LDLT, and use of reduced-size graft had no significant impact on survival. Overall survival at 5 years following LDLT in children and infants with BA at our center was 95.6% and 93.2%, respectively. These are excellent outcomes when compared with other studies. (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) 27, 28) Consistent with recent reports demonstrating that the PELD system may not accurately reflect true mortality risk in small babies with BA because of the acute life-threatening complications that can occur in these young patients, (29) high PELD score was not identified as a risk factor for posttransplant mortality in this study. In view of the present trend of significantly improved outcomes in LDLT as a result of technical innovations by transplant surgeons, we believe that our findings are clinically relevant and that LDLT for post-Kasai BA should be timed before malnutrition develops in order to achieve more successful outcomes.
Malnutrition is a critical problem in children with BA, particularly during the first year of life. (29) Previous studies have shown that pretransplant weight or height deficit is associated with more hospital stays, greater hospital costs, and inferior patient and graft survival after LT. (9, 30, 31) These studies support our results. This study suggests that greater blood loss and higher incidence of bacteremia in infants with BW deficit might contribute to poor outcomes. Although a few studies have reported a relationship between malnutrition and higher transfusion requirements during LT (32) and a relationship between malnutrition and postoperative sepsis in adult LDLT, (33) the precise mechanism has not been clarified. We speculate that PV hypoplasia due to liver cirrhosis or previous KPE results in poor synthetic capability (from hypoalbuminemia), which also leads to growth retardation, and therefore, hypoalbuminemia might further worsen immune function or cause coagulopathy despite normal pretransplant clotting function. This vicious circle may be closely related to poor posttransplant outcome.
In this study, the incidence of PV complications tended to be higher in infants than in older children, and PV hypoplasia was identified as an independent risk factor for morbidity after LDLT. Although we used interposition vein grafts or alternative innovative techniques, such as a more efficient approach to collateral vein ligation in infants with sclerotic/smallerdiameter PV than in other pediatric recipients, (4, 5, 34) we must acknowledge that infants with PV hypoplasia or PV flow regurgitation had a relatively higher incidence of PV complications after LDLT. In addition, PV diameter was found to be significantly smaller in infants with BW deficit than in those with no BW deficit. These results suggest that the development of PV hypoplasia after KPE may lead to severe malnutrition before LDLT. Some infants failed to gain weight appropriately despite aggressive nutritional management after referral to our center, and their malnutrition status was associated with poor survival after LDLT. Therefore, early referral to transplant centers before severe malnutrition develops would be an important strategy to achieve more successful outcomes.
In this study, smaller babies (BW < 6 kg) and infants were not at significantly increased risk for poor outcome after LT, and this finding conflicts with results of previous studies. (9, 12, 31, 35) Many studies have reported a correlation between low BW and increased incidence of vascular complications after LT. (35, 36) Although this study has statistical limitations due to the small number of patients who died, all these other studies were carried out more than 5 years ago, and surgical techniques have continued to evolve in recent years. First, over the last few decades, problems related to large-for-size grafts in small infants, including ischemia due to compression or vascular complications, can be overcome by using hyper-reduced LLS and segment 2 grafts. (17, 18, 36, 37) Indeed, survival has improved significantly after the introduction of the segment 2 graft (data not shown). Second, innovative procedures have been developed to achieve sufficient PV flow, especially in children with BA and PV hypoplasia, as previously mentioned. (6, 7, 34) Although the incidence of PV complications was relatively higher in infants than in older children in our study, the difference was not significant, and this is favorable compared with the incidence of PV complications in other experienced referral centers. (10, 12, 15) Additionally, we endeavor to evaluate indications carefully and plan LDLT as soon as possible after referral to our center. We consider that these efforts have improved posttransplant outcomes at our institution, especially in small infants.
Early evaluation of malnutrition in children prior to LDLT is difficult because anthropometric parameters are affected by edema, hepatomegaly, and ascites. Nutritional biological markers such as albumin, prealbumin, and transferrin are unreliable due to decompensated cirrhosis regardless of nutritional status. (29) Routine measurement of triceps skinfold thickness and mid-upper-arm circumference has been reported to be a better indicator of nutritional status in children, (29) and we consider the introduction of these indicators or new measurement methods in clinical practice is necessary based on the results of this study. At our center, nutritional supplementation for all patients was ensured by the expertise of a multidisciplinary team immediately after admission. A medium-chain triglyceride formula including adequate essential fatty acids was used. Although oral intake was preferred, nasogastric feeding was required when patients could not tolerate oral intake. Recent studies have demonstrated higher effectiveness of enteral nutrition with mediumchain triglyceride formula compared with oral nutrition in patients with BA awaiting possible LT. (38, 39) These nutritional supportive measures should be emphasized to improve outcomes after LDLT.
This study had certain limitations. First, this was a retrospective study and all patients were from a single institution, leading to potential selection biases including race, indications for surgery, and surgical techniques. Second, the low mortality rate was favorable but the statistical analysis was extremely limited, and we could not conduct multivariate analysis for patient survival. In addition, true risk factors for poor outcome might have been overlooked due to the small sample size for analysis. Ideally, a well-defined, nationwide, prospective study is needed to accurately evaluate independent risk factors for outcomes after LDLT.
In conclusion, this study demonstrated that high PELD score and PV hypoplasia were independent risk factors for morbidity and that BW deficit was associated with poor overall survival in infants with postKasai BA after LDLT. However, LDLT in infants with post-Kasai BA appears to be a feasible option with excellent patient survival in an experienced referral center. The necessity of early referral to a transplant center before malnutrition develops and early initiation of nutritional management should be emphasized to achieve more successful outcomes.
